Point-of-care p24 antigen detection for early infant diagnosis of HIV infection: cross-sectional and longitudinal studies in Zambia.
Catherine G SutcliffeJane MutangaNkumbula MoyoAbhishek K AgarwalJessica L SchueMutinta HamahuwaKara M PalamountainMark J FisherRobert ElghanianPhilip E ThumaWilliam J MossPublished in: BMC infectious diseases (2021)
Considering the high specificity and moderate sensitivity that increased with age, the LYNX test could be of value for early infant diagnosis for infants ≥4 weeks of age, particularly in rural areas where centralized testing leads to long delays. Point-of-care tests with moderate sensitivity and high specificity that are affordable, easy-to-use, and easily implemented and maintained should be developed to expand access to testing and deliver same-day results to infants in areas where it is not feasible to implement nucleic acid-based point-of-care assays.